Researchers examining the intimate lives of trauma survivors found that psychedelics have different effects on communication and emotional connection during sexual encounters. A recent global analysis showed that women who associated psychedelics with healing sexual trauma reported better intimate communication than men with similar trauma histories. The findings were published in the Journal of Sex Research.
Scientists are increasingly investigating substances such as psilocybin, ayahuasca, and lysergic acid diethylamide to treat mental health conditions. These specific drugs interact with the serotonin system in the brain, altering perception and emotional regulation. By disrupting rigid thought patterns, these substances can theoretically increase emotional openness and interpersonal awareness.
When a person takes a psychedelic substance, the substance modulates connections between key areas of the brain. This includes areas associated with self-referential thinking and deep emotional processing. By interrupting normal functional connections, a person’s traditional cognitive boundaries are temporarily relaxed. This particular state of mind can prompt deep-seated fears and unexpected re-evaluation of interpersonal relationships.
Many survivors of sexual violence experience persistent disruptions in their physiological and emotional responses. This trauma may manifest as sudden distress, general physical avoidance, or extreme difficulty maintaining trust in intimate settings. Because traditional treatments and medications do not work for all survivors, some turn to unregulated psychedelic use to overcome these lingering barriers.
Anecdotal reports suggest that the mind-altering effects of these drugs may help individuals process difficult memories and feel more connected to their partners. However, there is little empirical evaluation of how these substances actually function during sexual contact. Mason Levy, a public health researcher at the University of Queensland, led a study to quantify these subjective experiences.
The researchers wanted to compare the experiences of trauma survivors who found psychedelics helpful in their recovery with those who did not share that connection. They focused entirely on self-reported outcomes related to sexual communication and emotional connection. This sample is from the 2022 Global Drug Survey, an anonymous survey distributed around the world.
The study analyzed responses from 675 participants who reported having sex within four to six hours of taking a full dose of the psychedelic drug. The average age of respondents was approximately 33 years old, and the demographics skewed heavily toward employed whites. To isolate some of the trauma survivors, the team relied on a single survey question asking whether past psychedelic experiences had helped them cope with sexual trauma.
Within the dataset, 110 people reported that psychedelics helped them cope with such trauma. The remaining 565 participants served as the comparison group. Participants rated how their recent psychedelically modified sexual experience affected factors such as arousal, communication, and emotional connection, ranging from very negative to very positive.
To ensure statistical stability, the researchers combined both ends of the rating scale and eliminated categories with very few responses. We then used regression models to identify patterns, adjusting for age and gender differences. Analyzes revealed that trauma survivors were overall less likely to report relatively improved communication during psychedelic sexual encounters compared to non-trauma groups. Although a small subset of survivors chose the highest possible positive rating for communication, the difference in that particular number was not statistically significant.
The research team found similar results regarding emotional connections across the dataset. Overall, trauma survivors reported slightly higher levels of emotional connection during transition sexual episodes than the comparison group. However, the exact model showed that this overall difference was not statistically significant.
A different picture emerged when researchers focused solely on the internal dynamics of trauma survivor groups. Among these participants, women were significantly more likely than men to report that psychedelics improved their communication with sexual partners. Women in this group were significantly more likely to report increased emotional connection.
The researchers noted that the differences between nonbinary individuals and men in the trauma survivor group were not statistically significant. This suggests that the relational benefits of these substances in trauma survivors vary widely depending on gender. The authors hypothesize that broader social norms regarding intimacy play a role in how different people respond to these chemicals. Women are often socialized to prioritize emotional openness, which is consistent with the form of psychological vulnerability that psychedelic drugs typically amplify.
Conversely, men may experience different baseline expectations for physical intimacy, which may dampen the emotional highs brought on by drugs. Researchers sometimes refer to an altered state of shared insight and mutual vulnerability between partners as psychedelic intimacy. Because psychedelics induce emotional expansion at a neurobiological level, the resulting changes may better map to typical intimacy scenarios experienced by women.
Understanding these personal boundaries is necessary to develop effective harm reduction strategies. Many people who use these substances to cope with trauma do so in underground networks, far from clinical oversight. In an unregulated sexual environment, psychedelics pose physical and psychological risks such as dissolving boundaries, high suggestibility, and sudden distress.
Changes in drug regulations are changing the mental health treatment landscape internationally. Jurisdictions such as Oregon have established regulatory frameworks for the use of psilocybin, and Australia recently reclassified certain hallucinogens to authorize psychiatric prescription for conditions such as post-traumatic stress disorder. As these treatments become more available, harm reduction advocates must prioritize messages that recognize that these substances do not universally erase interpersonal trauma barriers.
The researchers outlined several limitations with the dataset. Because this study represents a single snapshot in time, the cross-sectional design cannot prove that the drug physically caused the reported changes in intimacy. The study relied heavily on retrospective self-reports, requiring participants to assess their past changed states through the lens of their current psychological well-being. A person’s current mood can easily change memories of past traumatic events or intimate encounters.
The comparison group in this study was also highly heterogeneous. This group likely included people who had never experienced sexual trauma, as well as people who had experienced trauma but for whom psychedelics did not help. Combining these different experiences into a single control group obscures subtle trends in the data. The lack of a standard definition leaves room for great variation in how people process their life histories.
The definition of sexual trauma was determined entirely by the participants, with no clinical validation or details regarding the severity of past events. The survey questions asked only whether participants felt helped by the substance, not whether they took the drug with the strict intention of healing. Unmeasured variables such as the background of the relationship, the specific type of drug consumed, and the dose may have significantly influenced the results.
The researchers recommend future longitudinal studies that follow individuals over time. Observing these interpersonal changes in a controlled clinical setting may reveal whether emotional changes persist beyond the immediate drug experience. Future research could also help formally standardize the measurement of psychedelic-induced intimacy and build a robust framework for people seeking alternative treatments for trauma.
The study, “Psychedelics and Sexual Trauma: Effects on Communication and Emotional Connection,” was authored by Mason Levy, Benjamin Bonenti, Timothy Piatkowski, Jason Ferris, Alex Frankovich, Monica Barratt, Emma L. Davis, Adam Winstock, and Cenil Pljevic.
